Pluri Inc. Foreign Currency Cash Flow Hedge Asset at Fair Value
Pluri Inc. (PLUR) had Foreign Currency Cash Flow Hedge Asset at Fair Value of $40.00 thousand as of 2013-12-31, per its 10-Q filed 2014-02-05.
Discontinued › Notes › Derivative Instruments and Hedging Activities › Summary of Derivative Instruments › Foreign Currency Derivatives
us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue · last filed 2014-02-05
- 2013-12-31: Foreign Currency Cash Flow Hedge Asset at Fair Value $40.00K.
| Period end | Foreign Currency Cash Flow Hedge Asset at Fair Value |
|---|---|
| 2013-12-31 | $40.00K 10-Q · filed 2014-02-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |